EFFECTS OF ALPHA-2-ADRENERGIC AND BETA-ADRENERGIC AGONISM ON GLUCAGON-SECRETION FROM PERFUSED PANCREASES OF NORMAL AND STREPTOZOCIN-INDUCED DIABETIC RATS
EFFECTS OF ALPHA-2-ADRENERGIC AND BETA-ADRENERGIC AGONISM ON GLUCAGON-SECRETION FROM PERFUSED PANCREASES OF NORMAL AND STREPTOZOCIN-INDUCED DIABETIC RATS
复制标题
DOI:
10.1016/0026-0495(93)90025-j
复制
发表时间:
1993-08-01
影响因子:
9.8
通讯作者:
SARUTA, T
中科院分区:
文献类型:
--
作者:
HIROSE, H;MARUYAMA, H;SARUTA, T
Insulin secretion is known to be inhibited by α2-adrenergic agonism and stimulated by β-adrenergic agonism in both experimental animals and humans. In contrast, adrenergic regulation of glucagon secretion remains controversial. This study was designed to determine the effects of α2- and β-adrenergic agonism on islet α cells, using isolated perfused pancreata of normal and streptozocin-induced diabetic (STZ-D) rats. The α2-adrenoceptor agonist clonidine at a concentration of 10−7mol/L significantly stimulated glucagon secretion as compared with basal levels in both normal (1,286 ± 90v417 ± 53 ng/L,P< .01) and STZ-D rats (551 ± 86v130 ± 19 ng/L,P< .01). Also, the β-adrenoceptor agonist isoproterenol at a concentration of 10−7mol/L significantly stimulated glucagon secretion as compared with basal levels in both normal (751 ± 130v347 ± 41 ng/L,P< .05) and STZ-D rats (182 ± 22v92 ± 20 ng/L,P< .01). Furthermore, these α2- and β-agonistic effects were almost completely inhibited in the presence of the α2-adrenoceptor antagonist yohimbine and the β-agonistic effects were almost propranolol at a concentration of 10−6mol/L, respectively. Insulin secretion was markedly reduced in STZ-D rats. These results suggest that even in a severely diabetic state, not only β- but also α2-adrenergic agonism stimulates glucagon secretion from rat pancreatic α cells.